
© f9photos/iStockYour breath might be bad, but it's also amazing.
Your terrible breath is trying to tell you something—and not just that it's time to crack open a bottle of Listerine. Within that cloud of onion and stale tuna fish odors are hundreds of chemical compounds, which combine in your mouth to create a ratio as unique as a fingerprint.
By analyzing that ratio, researchers have come up with a powerful new way to detect the signatures of various diseases, from prostate cancer to Parkinson's.Today in the journal
American Chemical Society Nano, researchers unveil a sensor array that identifies and captures the unique "breathprint" of 17 different diseases. The researchers hope that their array, which uses artificial intelligence to match up the varying levels and ratios of 13 key chemical compounds found in human breath to different diseases, will pave the way for a versatile medical diagnostic tool. After sampling the breath of more than 1,400 people, they found that their technique was able to discriminate among diseases with 86 percent accuracy.
The science behind the scent of a person's breath lies within the suite of organic chemical compounds that we routinely expel into the air with every laugh, yell or sigh. These compounds often come marked with the signs of biochemical changes wrought by specific diseases—a phenomenon that forms the basis of modern breath diagnostics. The problem is, there's a lot of background noise to sift through: In a cloud of exhaled breath, you'll typically see hundreds of these compounds.
Ancient physicians dating back to 400 BC knew there was something to be gleaned from sniffing a sick person's breath. The famed Greek physician Hippocrates, among others, used to smell his patients' breath to find out what ailed them. (Even worse, some physicians
used to smell their patients' urine or stool.) We've gotten slightly more sophisticated since then; breath analysis has been successfully employed to
diagnose cirrhosis of the liver,
diabetes and
colorectal cancer. There's even a dedicated
Journal of Breath Research.
But previously, such efforts have mainly been used to detect a single disease. In the new study, Hossam Haick, a nanotech expert at
Technion—Israel Institute of Technology, and several dozen international collaborators aimed to lay the groundwork for a general diagnostic tool to identify the breath signatures of many diseases, including kidney failure, lung cancer, Crohn's disease, MS, prostate and ovarian cancer, and more. Their array first assesses each compound's relative abundance within a person's breath, and then compares disease signatures against healthy individuals.